Half-yearly Report
TOTAL
Second Quarter and First Half 2011 Results
Total (Paris:FP) (LSE:TTA) (NYSE:TOT):
 |  | 2Q11 |  |
Change
vs 2Q10 |
 | 1H11 |  |
Change
vs 1H10 |
 | ||||||||
Adjusted net income1 |
||||||||
 | ||||||||
|
2.8 | - 6% | 5.9 | +12% | ||||
|
4.0 | +7% | 8.3 | +19% | ||||
 | ||||||||
|
1.24 | -6% | 2.62 | +12% | ||||
 |
1.78 Â Â |
+6% Â Â |
3.67 Â Â |
+18% Â Â |
||||
Net income (Group share) (B€) |
2.7 |
-12% |
6.7 |
+17% |
||||
 |  |  |  |  |  | |||
Net-debt-to-equity ratio of 24.3% at June 30, 2011 | ||||||||
Hydrocarbon production of 2,311 kboe/d in 2Q 2011 Interim dividend for 2Q11 of 0.57 € per share payable in December 20112 |
Commenting on the results, Chairman and CEO Christophe de Margerie said :
« The combination of sustained global demand and geopolitical
troubles increased tensions in the oil market during the second quarter.
In this environment, Total continued to develop and rebalance its
portfolio in accordance with its commitment to sustainable growth.
The
net result for the quarter increased by 7% in dollars compared to the
second quarter 2010, reflecting the benefit of a more favorable
environment, which more than offset the negative impacts of portfolio
changes, higher maintenance, shutdowns in Libya, and continued weak
refining margins in Europe.
Exploration success in Bolivia
and Angola, a new permit in Qatar, a larger stake for Total in the Tempa
Rossa field in Italy, entry into shale gas concessions in Poland and the
launch of two offshore projects in Norway open new perspectives for
growth. In addition, the acquisition of California-based SunPower
delivers on the commitment to new energies, placing Total among the
world leaders in the fast-growing solar sector. At the same time, the
Group finalized agreements to sell several non-core assets, including
its interest in the Gassled pipeline network in Norway and the bulk of
its UK marketing assets.
With a strong balance sheet and a
dynamic pace of execution in all of the Group’s segments, Total begins
the second half of 2011 very confident in its outlook for profitable
growth to benefit all of its stakeholders »
2Q11 | Â | 1Q11 | Â | 2Q10 | Â |
2Q11 vs 2Q10 |
 |
in millions of euros except earnings per share and number of shares |
 | 1H11 |  | 1H10 |  |
1H11 vs 1H10 |
45,009 | 46,029 | 41,329 | +9% | Sales | 91,038 | 78,932 | +15% | |||||||
5,896 | 6,369 | 5,461 | +8% | Adjusted operating income from business segments | 12,265 | 9,967 | +23% | |||||||
2,901 | 3,363 | 2,960 | -2% | Adjusted net operating income from business segments | 6,264 | 5,243 | +19% | |||||||
2,457 | 2,849 | 2,203 | +12% |
-- Upstream |
5,306 | 4,174 | +27% | |||||||
197 | 276 | 483 | -59% |
-- Downstream |
473 | 638 | -26% | |||||||
247 | 238 | 274 | -10% |
-- Chemicals |
485 | 431 | +13% | |||||||
2,794 | 3,104 | 2,961 | -6% | Adjusted net income | 5,898 | 5,257 | +12% | |||||||
1.24 | 1.38 | 1.32 | -6% | Adjusted fully-diluted earnings per share (euros) | 2.62 | 2.34 | +12% | |||||||
2,255.5 | 2,251.1 | 2,242.5 | +1% | Fully-diluted weighted-average shares (millions) | 2,252.3 | 2,242.6 | - | |||||||
2,726 | 3,946 | 3,101 | -12% | Net income (Group share) | 6,672 | 5,714 | +17% | |||||||
7,570 | 5,683 | 3,446 | X2.2 |
Investments4 |
13,253 | 7,155 | +85% | |||||||
1,338 | 663 | 850 | +57% | Divestments | 2,001 | 1,898 | +5% | |||||||
6,232 | 5,020 | 2,596 | X2.4 | Net investments | 11,252 | 5,257 | X2.1 | |||||||
5,064 | 5,714 | 4,942 | +2% | Cash flow from operations | 10,778 | 10,202 | +6% | |||||||
4,675 | 4,945 | 5,250 | -11% | Adjusted cash flow from operations | 9,620 | 8,989 | +7% | |||||||
2Q11 | 1Q11 | 2Q10 |
2Q11 vs 2Q10 |
in millions of dollars 5 |
1H11 | 1H10 |
1H11 vs 1H10 |
|||||||
64,772 | 62,968 | 52,521 | +23% | Sales | 127,745 | 104,727 | +22% | |||||||
8,485 | 8,713 | 6,940 | +22% | Adjusted operating income from business segments | 17,210 | 13,224 | +30% | |||||||
4,175 | 4,601 | 3,762 | +11% | Adjusted net operating income from business segments | 8,790 | 6,956 | +26% | |||||||
3,536 | 3,897 | 2,800 | +26% |
-- Upstream |
7,445 | 5,538 | +34% | |||||||
284 | 378 | 614 | -54% |
-- Downstream |
664 | 846 | -22% | |||||||
355 | 326 | 348 | +2% |
-- Chemicals |
681 | 572 | +19% | |||||||
4,021 | 4,246 | 3,763 | +7% | Adjusted net income | 8,276 | 6,975 | +19% | |||||||
1.78 | 1.89 | 1.68 | +6% | Adjusted fully-diluted earnings per share (euros) | 3.67 | 3.11 | +18% | |||||||
2,255.5 | 2,251.1 | 2,242.5 | +1% | Fully-diluted weighted-average shares (millions) | 2,252.3 | 2,242.6 | - | |||||||
3,923 | 5,398 | 3,941 | - | Net income (Group share) | 9,362 | 7,581 | +23% | |||||||
10,894 | 7,774 | 4,379 | X2.5 | Investments4 | 18,597 | 9,493 | X2.0 | |||||||
1,926 | Â | 907 | 1,080 | +78% | Divestments | 2,808 | 2,518 | +12% | ||||||
8,968 | Â | 6,867 | 3,299 | X2.7 | Net investments | 15,789 | 6,975 | X2.3 | ||||||
7,288 | Â | 7,817 | 6,280 | +16% | Cash flow from operations | 15,124 | 13,536 | +12% | ||||||
6,728 | Â | 6,765 | 6,672 | +1% | Adjusted cash flow from operations | 13,499 | 11,927 | +13% |
> Operating income
In the second quarter 2011, the Brent price averaged 117 $/b, an increase of 50% compared to the second quarter 2010 and 11% compared to the first quarter 2011. The European refining margin indicator (ERMI) averaged 16.3 $/t, a decrease of 48% compared to the second quarter 2010 and 34% compared to the first quarter 2011. The environment for the petrochemicals and specialty chemicals remained satisfactory.
The euro-dollar exchange rate averaged 1.44 $/€ in the second quarter 2011, 1.27 $/€ in the second quarter 2010 and 1.37 $/€ in the first quarter 2011. Expressed in euros, the Brent price averaged 81.3 €/b, an increase of 32% compared to the second quarter 2010.
In this environment, the adjusted operating income6 from the business segments was 5,896 M€, an increase of 8% compared to the second quarter 2010. Expressed in dollars, the increase was 22%.
The effective tax rate7 for the business segments was 59.3% in the second quarter 2011 compared to 53.7% in the second quarter 2010, essentially due to the lower weight of Downstream in the results, an increase in the effective tax rate for the Upstream related to income contribution mix effects, and an increase in UK petroleum taxes.
Adjusted net operating income from the business segments was 2,901 M€ compared to 2,960 M€ in the second quarter 2010, a decrease of 2%.
Expressed in dollars, adjusted net operating income from the business segments was 4.2Â billion dollars (B$), an increase of 11% compared to the second quarter 2010.
> Net income (Group share)
Adjusted net income was 2,794 M€ in the second quarter 2011 compared to 2,961 M€ in the second quarter 2010, a decrease of 6%. Expressed in dollars, adjusted net income increased by 7%.
Effective July 1, 2010, the Group no longer accounts for its interest in Sanofi as an equity affiliate. In the second quarter 2011, the Group received dividend income of 115 M€ after taxes from Sanofi. In the second quarter 2010, the contribution to the Group’s adjusted net income from its interest in Sanofi was 141 M€.
Adjusted net income excludes the after-tax inventory effect, special items and from January 1, 2011, the effect of changes in fair value8:
Net income (Group share) was 2,726 M€ compared to 3,101 M€ in the second quarter 2010.
The effective tax rate for the Group was 59.4% in the second quarter 2011.
Adjusted fully-diluted earnings per share, based on 2,255.5 million fully-diluted weighted-average shares, was €1.24 compared to €1.32 in the second quarter 2010, a decrease of 6%.
Expressed in dollars, adjusted fully-diluted earnings per share increased 6% to $1.78.
> Investments – divestments9
Investments, excluding acquisitions and including changes in non-current loans, were 3.5 B€ (5.0 B$) in the second quarter 2011 compared to 3.1 B€ (3.9 B$) in the second quarter 2010.
Acquisitions were 4.0 B€ (5.8 B$) in the second quarter 2011, comprised essentially of the acquisition of 12% of Novatek and 60% of SunPower.
Asset sales in the second quarter 2011 were 1.2 B€ (1.8 B$), including mainly the Group’s interest in its Cameroon E&P subsidiary, part of the Joslyn project in Canada and the sale of Sanofi shares.
Net investments10 were 6.2 B€ (9.0 B$) in the second quarter 2011 compared to 2.6 B€ (3.3 B$) in the second quarter 2010.
> Cash flow
Cash flow from operations was 5,064 M€ in the second quarter 2011 compared to 4,942 M€ the second quarter 2010. Expressed in dollars, cash flow from operations was 7.3 B$.
Adjusted cash flow from operations 11 was 4,675 M€, a decrease of 11% compared to the second quarter 2010. Expressed in dollars, adjusted cash flow from operations was 6.7 B$, an increase of 1%.
The Group’s net cash flow12 was a negative 1,168 M€ compared to a positive 2,346 M€ in the second quarter 2010. Expressed in dollars, the Group’s net cash flow was a negative 1.7 B$ in the second quarter 2011 compared to a positive 3.0 B$ in the second quarter 2010, reflecting essentially the significant level of acquisitions finalized during the quarter.
> Operating income
Compared to the first half 2010, the average Brent price increased by 44% to 111.1Â $/b. The European refining margin indicator (ERMI) averaged 20.4 $/t compared to 30.4 $/t in the first half 2010. The environment for the petrochemicals and specialty chemicals remained generally favorable.
The euro-dollar exchange rate averaged 1.40 $/€ compared to 1.33 $/€ in the first half 2010. Expressed in euros, the Brent price averaged 79.2 €/b, an increase of 36% compared to the second half 2010.
In this environment, the adjusted operating income from the business segments was 12,265 M€, an increase of 23% compared to the first half 201013.
The effective tax rate for the business segments was 56.9% in the first half 2011 compared to 55.4% in the first half 2010.
Adjusted net operating income from the business segments was 6,264 M€ compared to 5,243 M€ in the first half 2010, an increase of 19%.
Expressed in dollars, adjusted net operating income from the business segments increased by 26%.
> Net income (Group share)
Adjusted net income was 5,898 M€ in the first half 2011, an increase of
12% compared to the 5,257 M€ in the first half 2010. Expressed in
dollars, adjusted net income increased by 19%.
Effective July 1,
2010, the Group no longer accounts for its interest in Sanofi as an
equity affiliate. In the first half 2011, the Group received dividend
income of 115 M€ after taxes from Sanofi. In the first half 2010, the
contribution to the Group’s adjusted net income from its interest in
Sanofi was 290 M€.
Adjusted net income excludes the after-tax inventory effect, special items and from January 1, 2011, the effect of changes in fair value 14:
Net income (Group share) was 6,672 M€ compared to 5,714 M€ in the first half 2010.
The Group did not buy back shares in the first half 2011. On June 30, 2011, there were 2,258.3 million fully-diluted shares compared to 2,243.6 on June 30, 2010.
Adjusted fully-diluted earnings per share, based on 2,252.3 million fully-diluted weighted-average shares, was €2.62 compared to €2.34 in the first half 2010, an increase of 12%.
Expressed in dollars, adjusted fully-diluted earnings per share was $3.67 compared to $3.11 in the first half 2010, an increase of 18%.
> Investments – divestments15
Investments, excluding acquisitions and including changes in non-current loans, were 6.3 B€ (8.8 B$) in the first half 2011 compared to 5.5 B€ (7.3 B$) in the first half 2010.
Acquisitions were 6.5 B€ (9.2 B$) in the first half 2011, comprised essentially of the acquisition of interests in Fort Hills and Voyageur in Canada, an additional 7.5% interest in the GLNG project in Australia, a 12% stake in Novatek and 60% of SunPower.
Asset sales in the first half 2011 were 1.5 B€ (2.2 B$), essentially comprised of sales of Sanofi shares, the Group’s interest in its Cameroon E&P subsidiary and part of the Joslyn project in Canada.
Net investments were 11.3 B€ (15.8 B$) in the first half 2011, compared to 5.3 B€ (7.0 B$) in the first half 2010.
> Cash flow
Cash flow from operations was 10,778 M€ in the first half 2011, an increase of 6% compared to the first half 2010.
Adjusted cash flow from operations 16 was 9,620 M€, an increase of 7%. Expressed in dollars, adjusted cash flow from operations was 13.5 B$, an increase of 13%.
The Group’s net cash flow 17 was a negative 474 M€ compared to a positive 4,945 M€ in the first half 2010. Expressed in dollars, the Group’s net cash flow was a negative 0.7 B$ in the first half 2011.
The net-debt-to-equity ratio was 24.3% on June 30, 2011 compared to 22.7% on June 30, 201018, in line with the Group’s target range.
Upstream
> Environment – liquids and gas price realizations*
2Q11 | Â | 1Q11 | Â | 2Q10 | Â |
2Q11 vs 2Q10 |
 |  |  | 1H11 |  | 1H10 |  |
1H11 vs 1H10 |
117.0 | 105.4 | 78.2 | +50% | Brent ($/b) | 111.1 | 77.3 | +44% | |||||||
110.6 | 99.5 | 74.8 | +48% | Average liquids price ($/b) | 104.6 | 74.5 | +40% | |||||||
6.60 | 6.19 | 4.82 | +37% | Average gas price ($/Mbtu) | 6.39 | 4.94 | +29% | |||||||
76.9 | 71.7 | 54.8 | +40% | Average hydrocarbons price ($/boe) | 74.1 | 55.2 | +34% |
* consolidated subsidiaries, excluding fixed margin and buy-back contracts.
> Production
2Q11 | Â | 1Q11 | Â | 2Q10 | Â |
2Q11 vs 2Q10 |
 | Hydrocarbon production |  | 1H11 |  | 1H10 |  |
1H11 vs 1H10 |
2,311 | 2,371 | 2,359 | -2% | Combined production (kboe/d) | 2,341 | 2,393 | -2% | |||||||
1,197 | 1,293 | 1,327 | -10% | = Liquids (kb/d) | 1,245 | 1,350 | -8% | |||||||
6,077 | 5,880 | 5,549 | +10% | = Gas (Mcf/d) | 5,979 | 5,689 | +5% |
Hydrocarbon production was 2,311 thousand barrels of oil equivalent per day (kboe/d) in the second quarter 2011, a decrease of 2% compared to the second quarter 2010, essentially as a result of :
In the first half 2011, hydrocarbon production was 2,341 kboe/d, a decrease of 2% compared to the first half 2010, essentially as a result of :
Results
2Q11 | Â | 1Q11 | Â | 2Q10 | Â |
2Q11 vs 2Q10 |
 | In millions of euros |  | 1H11 |  | 1H10 |  |
1H11 vs 1H10 |
5,390 | 5,821 | 4,607 | +17% | Adjusted operating income* | 11,211 | 8,768 | +28% | |||||||
2,457 | 2,849 | 2,203 | +12% | Adjusted net operating income* | 5,306 | 4,174 | +27% | |||||||
366 | 374 | 271 | +35% |
|
740 | 606 | +22% | |||||||
 |  |  |  |  |  |  |  | |||||||
6,868 | 5,232 | 2,723 | X2.5 | Investments | 12,100 | 5,866 | X2.1 | |||||||
921 | 335 | 174 | X5.3 | Divestments | 1,256 | 261 | X4.8 | |||||||
5,605 | 4,643 | 4,154 | +35% | Cash flow from operating activities | 10,248 | 8,834 | +16% | |||||||
4,010 | 4,271 | 3,895 | +3% | Adjusted cash flow | 8,281 | 7,019 | +18% |
* detail of adjustment items shown in the business segment information annex to financial statements.
Adjusted net operating income from the Upstream segment was 2,457 M€ in the second quarter 2011 compared to 2,203 M€ in the second quarter 2010, an increase of 12%.
Expressed in dollars, the increase was 26%, reflecting mainly the increase in hydrocarbon prices.
The effective tax rate for the Upstream segment was 61.6% compared to 58.3% in the second quarter 2010, essentially due to income contribution mix effects as well as higher UK petroleum taxes. The effective tax rate for the Upstream segment was 57.6% in the first quarter 2011.
Adjusted net operating income from the Upstream segment in the first
half 2011 was 5,306 M€ compared to 4,174 M€ in the first half 2010, an
increase of 27%.
Expressed in dollars, adjusted net operating
income from the Upstream segment was 7.4 B$, an increase of 34% compared
to the first half 2010, reflecting essentially the increase in
hydrocarbon prices.
The return on average capital employed (ROACE20) for the Upstream segment was 21% for the twelve months ended June 30, 2011, compared to 22% for the twelve months ended March 31, 2011, and 21% for the full year 2010.
The annualized second quarter 2011 ROACE for the Upstream segment was 22%.
Downstream
> Refinery throughput and utilization rates*
2Q11 | Â | 1Q11 | Â | 2Q10 | Â |
2Q11 vs 2Q10 |
 |  |  | 1H11 |  | 1H10 |  |
1H11 vs 1H10 |
1,855 | 2,012 | 2,141 | -13% | Total refinery throughput (kb/d) | 1,934 | 2,067 | -6% | |||||||
692 | 745 |
784 |
-12% |
-- France |
719 | 732 | -2% | |||||||
877 |
1,047 |
1,110 | -21% |
-- Rest of Europe |
962 | 1,080 | -11% | |||||||
286 | 220 | 247 | +16% |
-- Rest of world |
253 | 255 | -1% | |||||||
Utilization rates** | ||||||||||||||
75% | 79% | 78% |
-- Based on crude only |
77% | 75% | |||||||||
79% | 85% | 83% | Â |
-- Based on crude and other feedstock |
82% | 80% | Â |
* includes share of CEPSA and, starting October 2010, of TotalErg
**
based on distillation capacity at the beginning of the year
In the second quarter 2011, refinery throughput decreased by 13% compared to the second quarter 2010 and by 8% compared to the first quarter 2011, mainly due to scheduled turnarounds at the Grandpuits, Leuna and Antwerp refineries.
The utilization rate based on crude and other feedstock was 79% in the second quarter 2011 compared to 85% in the first quarter 2011 and 83% in the second quarter 2010.
In the first half 2011, refinery throughput decreased by 6% compared to the first half 2010, reflecting essentially the work at the Lindsey and Port Arthur refineries as well as the scheduled turnarounds in the second quarter.
> Results
2Q11 | Â | 1Q11 | Â | 2Q10 | Â |
2Q11 vs 2Q10 |
 |
in millions of euros (except the ERMI) |
 | 1H11 |  | 1H10 |  | 1H11 vs 1H10 |
16.3 | 24.6 | 31.2 | -48% |
European refining margin
indicator - ERMI ($/t) |
20.4 | 30.4 | -33% | |||||||
 |  |  |  |  |  |  |  | |||||||
228 | 286 | 549 | -58% | Adjusted operating income* | 514 | 740 | -31% | |||||||
197 | 276 | 483 | -59% | Adjusted net operating income* | 473 | 638 | -26% | |||||||
23 | 24 | 44 | -48% |
|
47 | 58 | -19% | |||||||
 |  |  |  |  |  |  |  | |||||||
462 | 264 | 562 | -18% | Investments | 726 | 1,018 | -29% | |||||||
28 | 23 | 11 | X2.5 | Divestments | 51 | 38 | +34% | |||||||
7 | 1,158 | 1,042 | n/a | Cash flow from operating activities | 1,165 | 1,496 | -22% | |||||||
398 | 360 | 774 | -49% | Adjusted cash flow | 758 | 1,097 | -31% |
* detail of adjustment items shown in the business segment information annex to financial statements.
The European refining margin indicator (ERMI) averaged 16.3 $/t in the second quarter 2011, or approximately one-half of the 31.2 $/t average of the second quarter 2010.
Adjusted net operating income from the Downstream segment was 197 M€ in the second quarter 2011, compared to 483 M€ in the second quarter 2010. Expressed in dollars, adjusted net operating income from the Downstream segment was 284 M$ compared to 614 M$ in the second quarter 2010.
Adjusted net operating income from the Downstream segment in the first half 2011 was 473 M€, a decrease of 26% compared to the first half 2010. Expressed in dollars, adjusted net operating income from the Downstream segment in the first half 2011 was 664 M$, a decrease of 22% compared to the first half 2010. This decrease reflects essentially the unfavorable market conditions for refining and the reduced capacity of European refining during the second quarter due to maintenance.
The ROACE21 for the Downstream segment was 6% for the twelve months ended June 30, 2011, compared to 9% for the twelve months ended March 31, 2011, and 8% for the full year 2010.
The annualized second quarter 2011 ROACE for the Downstream segment was 5%.
Chemicals
2Q11 | Â | 1Q11 | Â | 2Q10 | Â |
2Q11 vs 2Q10 |
 | in millions of euros |  | 1H11 |  | 1H10 |  | 1H11 vs 1H10 |
5,291 | 5,105 | 4,589 | +15% | Sales | 10,396 | 8,812 | +18% | |||||||
3,400 | 3,319 | 2,794 | +22% |
-- Base chemicals |
6,719 | 5,326 | +26% | |||||||
1,891 | 1,786 | 1,784 | +6% |
-- Specialties |
3,677 | 3,475 | +6% | |||||||
 |  |  |  |  |  |  |  | |||||||
278 | 262 | 305 | -9% | Adjusted operating income* | 540 | 459 | +18% | |||||||
247 | 238 | 274 | -10% | Adjusted net operating income* | 485 | 431 | +13% | |||||||
132 | 119 | 149 | -11% |
|
251 | 193 | +30% | |||||||
118 | 121 | 124 | -5% |
|
239 | 241 | -1% | |||||||
 |  |  |  |  |  |  |  | |||||||
209 | 171 | 144 | +45% | Investments | 380 | 238 | +60% | |||||||
12 | 14 | 328 | -96% | Divestments | 26 | 334 | -92% | |||||||
138 | (144) | 477 | -71% | Cash flow from operating activities | (6) | 387 | n/a | |||||||
336 | 289 | 418 | -20% | Adjusted cash flow | 625 | 646 | -3% |
* detail of adjustment items shown in the business segment information annex to financial statements.
In the second quarter 2011, the environment for Chemicals remained favorable, in line with the second quarter 2010.
Sales for the Chemical segment were 5.3 B€, an increase of 15% compared to the second quarter 2010.
The adjusted net operating income for the Chemicals segment was 247 M€ compared to 274 M€ in the second quarter 2010, which reflected strong petrochemical margins in Europe and the U.S. Results for the Specialty chemicals were in line with the strong results shown over recent quarters in a still favorable environment.
In the first half 2011, adjusted net operating income for the Chemicals segment was 485 M€ compared to 431 M€ in the first half 2010. The increase reflects essentially the progress made by the Base chemicals in a generally favorable environment with, in particular, an increased contribution from activities in Qatar.
The ROACE22 for the Chemicals segment was 12% for the twelve months ended June 30, 2011, stable compared to the twelve months ended March 31, 2011, and the full year 2010.
The annualized second quarter 2011 ROACE for the Chemicals segment was 13%.
Net income for TOTAL S.A., the parent company, was 3,157 M€ in the first half 2011, compared to 2,941 M€ in the first half 2010.
The ROACE23 for the Group for the twelve months ended June
30, 2011, was 16% compared to 17% for the twelve months ended March 31,
2011 and 16% for the full year 2010. The annualized second quarter 2011
ROACE for the Group was 16%.
Return on equity for the twelve months
ended June 30, 2011, was 19%.
In October 2010, Total announced that starting in 2011 the interim dividend would be paid on a quarterly basis. For the interim dividend related to the second quarter 2011, the Board of Directors at its meeting on July 28, 2011, decided to pay on December 22, 201124 an interim dividend of 0.57 euros per share.
Total announced that it would not seek a renewal of its Global Tax Consolidation status in France. Effective 2011, the Group will use the prevailing French tax law.
Since the start of the third quarter 2011, the Brent price has continued to trade around 110 $/b but the environment for European refining has remained difficult.
In the Upstream, while the first results from high-potential exploration wells are expected in the second half, the Group plans to sanction several major projects, notably in Australia and Russia, to pursue the development of major new producing areas. At the same time, the fourth quarter start-up of Pazflor in Angola is expected to contribute substantially to near-term production growth.
In the Downstream and Chemicals, the Group expects to benefit fully from its new deep-conversion unit at the Port Arthur refinery in the U.S. that was started up in the second quarter, while continuing to improve the competitiveness of its main Downstream-Chemicals platforms.
In the coming months, Total expects to finalize the pending acquisitions and asset sales in all of its operating segments, confirming its strategy of rebalancing its activities while maintaining the strength of its balance sheet.
â– â– â–
To listen to CFO Patrick de la Chevardière’s conference call with financial analysts today at 15:00 (Paris time) please log on to www.total.com or call +44 (0)207 162 0177 in Europe or +1 334 323 6203 in the U.S. For a replay, please consult the website or call +44 207 031 4064 in Europe or 1 954 334 0342 in the US (code : 897 455).
This document does not constitute the Financial Report for the first half which will be separately published, in accordance with article L.451-1-2 III of the French Code monétaire et financier, and is available on our web site www.total.com or upon request at the company’s headquarters.
The June 30, 2011 notes to the consolidated financial statements are
available on the Total web site (www.total.com).This
document may contain forward-looking statements, including within the
meaning of the Private Securities Litigation Reform Act of 1995, notably
with respect to the financial condition, results of operations,
business, strategy and plans of TOTAL.
Such statements are
based on a number of assumptions that could ultimately prove inaccurate,
and are subject to a number of risk factors, including currency
fluctuations, the price of petroleum products, the ability to realize
cost reductions and operating efficiencies without unduly disrupting
business operations, environmental regulatory considerations and general
economic and business conditions. Neither TOTAL nor any of its
subsidiaries assumes any obligation to update publicly any
forward-looking statement, whether as a result of new information,
future events or otherwise. Further information on factors which could
affect the company’s financial results is provided in documents filed by
the Group with the French Autorité des Marchés Financiers and the U.S.
Securities and Exchange Commission (“SECâ€).
Financial information by business segment is reported in accordance
with the internal reporting system and shows internal segment
information that is used to manage and measure the performance of TOTAL.
Performance
indicators excluding the adjustment items, such as adjusted operating
income, adjusted net operating income, and adjusted net income are meant
to facilitate the analysis of the financial performance and the
comparison of income between periods.
Adjustment items
include:
(i) Special
items
Due to their unusual nature or particular
significance, certain transactions qualified as "special items" are
excluded from the business segment figures. In general, special items
relate to transactions that are significant, infrequent or unusual.
However, in certain instances, transactions such as restructuring costs
or asset disposals, which are not considered to be representative of the
normal course of business, may be qualified as special items although
they may have occurred within prior years or are likely to occur again
within the coming years.
(ii)
Inventory valuation effect
The adjusted
results of the Downstream and Chemicals segments are presented according
to the replacement cost method. This method is used to assess the
segments’ performance and facilitate the comparability of the segments’
performance with those of its competitors.
In the
replacement cost method, which approximates the LIFO (Last-In,
First-Out) method, the variation of inventory values in the statement of
income is, depending on the nature of the inventory, determined using
either the month-end prices differential between one period and another
or the average prices of the period rather than the historical value.
The inventory valuation effect is the difference between the results
according to the FIFO (First-In, First-Out) and the replacement cost.
(iii)
Effect of changes in fair value
As from
January 1, 2011, the effect of changes in fair value presented as an
adjustment item reflects for some transactions differences between
internal measures of performance used by TOTAL’s management and the
accounting for these transactions under IFRS.
IFRS requires
that trading inventories be recorded at their fair value using
period-end spot prices. In order to best reflect the management of
economic exposure through derivative transactions, internal indicators
used to measure performance include valuations of trading inventories
based on forward prices.
Furthermore, TOTAL, in its trading
activities, enters into storage contracts, which future effects are
recorded at fair value in Group’s internal economic performance. IFRS
precludes recognition of this fair value effect.
(iv)
Until June 30, 2010, TOTAL’s equity share of adjustment items
reconciling “Business net income†to Net income attributable to equity
holders of Sanofi
The adjusted results (adjusted operating income, adjusted net operating income, adjusted net income) are defined as replacement cost results, adjusted for special items, excluding the effect of changes in fair value as from January 1st, 2011 and excluding TOTAL’s equity share of adjustment items related to Sanofi until June 30, 2010.
Dollar amounts presented herein represent euro amounts converted at
the average euro-dollar exchange rate for the applicable period and are
not the result of financial statements prepared in dollars.
Cautionary
Note to U.S. Investors – The SEC permits oil and gas companies, in their
filings with the SEC, to separately disclose proved, probable and
possible reserves that a company has determined in accordance with SEC
rules. We may use certain terms in this presentation, such as resources,
that the SEC’s guidelines strictly prohibit us from including in filings
with the SEC. U.S. investors are urged to consider closely the
disclosure in our Form 20-F, File N° 1-10888, available from us at
2, place Jean Millier – La Défense 6 – 92078 Paris – La Défense Cedex,
France, or at our Web site: www.total.com.
You can also obtain this form from the SEC by calling 1-800-SEC-0330 or
on the SEC’s Web site: www.sec.gov.
Second quarter and first half 2011 operating information by segment
2Q11 | Â | 1Q11 | Â | 2Q10 | Â | 2Q11 vs 2Q10 | Â | Combined liquids and gas production by region (kboe/d) | Â | 1H11 | Â | 1H10 | Â | 1H11 vs 1H10 |
475 | 582 | 577 | -18% | Europe | 528 | 612 | -14% | |||||||
628 | 691 | 752 | -16% | Africa | 659 | 749 | -12% | |||||||
571 | 581 | 515 | +11% | Middle East | 576 | 515 | +12% | |||||||
66 | 68 | 63 | +5% | North America | 67 | 65 | +3% | |||||||
190 | 185 | 184 | +3% | South America | 188 | 178 | +6% | |||||||
241 | 242 | 246 | -2% | Asia-Pacific | 241 | 250 | -4% | |||||||
140 | 22 | 22 | x6.4 | CIS | 82 | 24 | x3.4 | |||||||
2,311 | 2,371 | 2,359 | -2% | Total production | 2,341 | 2,393 | -2% | |||||||
605 | 500 | 434 | +39% | Includes equity and non-consolidated affiliates | 552 | 425 | +30% | |||||||
 |  |  |  |  |  |  |  | |||||||
2Q11 | 1Q11 | 2Q10 | 2Q11 vs 2Q10 | Liquids production by region (kb/d) | 1H11 | 1H10 | 1H11 vs 1H10 | |||||||
240 | 263 | 258 | -7% | Europe | 251 | 280 | -10% | |||||||
484 | 551 | 611 | -21% | Africa | 517 | 616 | -16% | |||||||
321 | 325 | 309 | +4% | Middle East | 323 | 305 | +6% | |||||||
26 | 32 | 30 | -13% | North America | 29 | 31 | -6% | |||||||
73 | 82 | 76 | -4% | South America | 78 | 74 | +5% | |||||||
28 | 28 | 30 | -7% | Asia-Pacific | 28 | 31 | -10% | |||||||
25 | 12 | 13 | +92% | CIS | 19 | 13 | +46% | |||||||
1,197 | 1,293 | 1,327 | -10% | Total production | 1,245 | 1,350 | -8% | |||||||
331 | 325 | 298 | +11% | Includes equity and non-consolidated affiliates | 328 | 291 | +13% |
2Q11 | Â | 1Q11 | Â | 2Q10 | Â | 2Q11 vs 2Q10 | Â | Gas production by region (Mcf/d) | Â | 1H11 | Â | 1H10 | Â | 1H11 vs 1H10 |
1,284 | 1,743 | 1,689 | -24% | Europe | 1,512 | 1,814 | -17% | |||||||
734 | 717 | 704 | +4% | Africa | 726 | 675 | +8% | |||||||
1,355 | 1,390 | 1,098 | +23% | Middle East | 1,372 | 1,143 | +20% | |||||||
226 | 204 | 191 | +18% | North America | 215 | 190 | +13% | |||||||
650 | 571 | 594 | +9% | South America | 611 | 574 | +6% | |||||||
1,209 | 1,202 | 1,220 | -1% | Asia-Pacific | 1,206 | 1,234 | -2% | |||||||
619 | 53 | 53 | x11.7 | CIS | 337 | 59 | X5.7 | |||||||
6,077 | 5,880 | 5,549 | +10% | Total production | 5,979 | 5,689 | +5% | |||||||
1,478 | 947 | 737 | x2.0 | Includes equity and non-consolidated affiliates | 1,214 | 723 | +68% |
2Q11 | Â | 1Q11 | Â | 2Q10 | Â | 2Q11 vs 2Q10 | Â | Liquefied natural gas | Â | 1H11 | Â | 1H10 | Â | 1H11 vs 1H10 |
3.34 | 3.38 | 3.00 | +11% | LNG sales* (Mt) | 6.73 | 5.85 | +15% |
* sales, Group share, excluding trading ; 2010 data restated to reflect volume estimates for Bontang LNG in Indonesia based on the 2010 SEC coefficient.
2Q11 | Â | 1Q11 | Â | 2Q10 | Â | 2Q11vs 2Q10 | Â | Refined products sales by region (kb/d)* | Â | 1H11 | Â | 1H10 | Â | 1H11 vs 1H10 |
1,855 | 1,967** | 1,881 | -1% | Europe | 1,910 | 1,915 | - | |||||||
310 | 294 | 301 | +3% | Africa | 302 | 294 | +3% | |||||||
104 | 102 | 115 | -10% | Americas | 103 | 131 | -21% | |||||||
169 | 167 | 163 | +4% | Rest of world | 169 | 154 | +10% | |||||||
2,438 | 2,530 | 2,460 | -1% | Total consolidated sales | 2,484 | 2,494 | - | |||||||
1,341 | 1,187 | 1,526 | -12% | Trading | 1,264 | 1,258 | - | |||||||
 |  |  |  |  |  |  |  | |||||||
3,779 | 3,717 | 3,986 | -5% | Total refined product sales | 3,748 | 3,752 | - |
* includes share of CEPSA and, starting October 2010, of TotalErg.
**
corrected 1Q11 data
Adjustment items
2Q11 | Â | 1Q11 | Â | 2Q10 | Â | in millions of euros | Â | 1H11 | Â | 1H10 |
(63) | - | (24) | Special items affecting operating income from the business segments | (63) | (74) | |||||
- | - | - |
|
- | - | |||||
- | - | (8) |
|
- | (8) | |||||
(63) | - | (16) |
|
(63) | (66) | |||||
(87) | 1,356 | 214 | Pre-tax inventory effect : FIFO vs. replacement cost | 1,269 | 700 | |||||
(55) | 84 | - | Effect of changes in fair value | 29 | - | |||||
 |  |  |  |  |  | |||||
(205) | 1,440 | 190 | Total adjustments affecting operating income from the business segments | 1,235 | 626 |
2Q11 | Â | 1Q11 | Â | 2Q10 | Â | in millions of euros | Â | 1H11 | Â | 1H10 |
47 | (167) | 11 | Special items affecting net income (Group share) | (120) | 25 | |||||
205 | 11 | 63 |
-- Gain on asset sales |
216 | 192 | |||||
- | - | (10) |
-- Restructuring charges |
- | (10) | |||||
(47) | - | (6) |
-- Impairments |
(47) | (65) | |||||
(111) | (178) | (36) |
-- Other |
(289) | (92) | |||||
(74) | 946 | 169 | After-tax inventory effect : FIFO vs. replacement cost | 872 | 513 | |||||
(41) | 63 | - | Effect of changes in fair value | 22 | - | |||||
- | - | (40) | Equity share of adjustment items related to Sanofi* | - | (81) | |||||
 |  |  |  |  |  | |||||
(68) | 842 | 140 | Total adjustments to net income | 774 | 457 |
* based on Total’s share in Sanofi of 5.7% at June 30, 2010. Effective July 1, 2010, Sanofi is no longer treated as an equity affiliate.
Effective tax rates
2Q11 | Â | 1Q11 | Â | 2Q10 | Â | Effective tax rate* | Â | 1H11 | Â | 1H10 |
61.6% | 57.6% | 58.3% | Upstream | 59.5% | 59.1% | |||||
59.4% | 55.6% | 53.3% | Group | 57.5% | 55.0% |
* tax on adjusted net operating income / (adjusted net operating income - income from equity affiliates, dividends received from investments, and impairments of acquisition goodwill + tax on adjusted net operating income).
Investments – Divestments
2Q11 | Â | 1Q11 | Â | 2Q10 | Â | 2Q11 vs 2Q10 | Â | in millions of euros | Â | 1H11 | Â | 1H10 | Â | 1H11 vs 1H10 |
3,467 | 2,787 | 3,067 | +13% | Investments excluding acquisitions* | 6,254 | 5,494 | +14% | |||||||
242 | 217 | 221 | +10% |
|
459 | 420 | +9% | |||||||
210 | (208) | 170 | +38% |
|
2 | 281 | n/a | |||||||
4,008 | 2,529 | 305 | x13.1 | Acquisitions | 6,537 | 1,522 | X4.3 | |||||||
7,475 | 5,316 | 3,372 | x2.2 | Investments including acquisitions* | 12,791 | 7,016 | +82% | |||||||
1,243 | 296 | 758 | +64% | Asset sales | 1,539 | 1,723 | -11% | |||||||
6,232 | 5,020 | 2,596 | x2.4 | Net investments | 11,252 | 5,257 | x2.1 | |||||||
 |  |  |  |  |  |  |  | |||||||
2Q11 | 1Q11 | 2Q10 | 2Q11 vs 2Q10 | expressed in millions of dollars *** | 1H11 | 1H10 | 1H11 vs 1H10 | |||||||
4,989 | 3,813 | 3,898 | +28% | Investments excluding acquisitions* | 8,776 | 7,289 | +20% | |||||||
348 | 297 | 281 | +24% |
|
644 | 557 | +16% | |||||||
302 | (285) | 216 | +56% |
|
3 | 373 | n/a | |||||||
5,768 | 3,460 | 388 | x14.9 | Acquisitions | 9,173 | 2,019 | x4.5 | |||||||
10,757 | 7,272 | 4,285 | x2.5 | Investments including acquisitions* | 17,948 | 9,309 | +93% | |||||||
1,789 | 405 | 963 | +86% | Asset sales | 2,160 | 2,286 | -6% | |||||||
8,968 | 6,867 | 3,299 | x2.7 | Net investments | 15,789 | 6,975 | x2.3 |
* includes changes in non-current loans.
** includes
net investments in equity affiliates and non-consolidated companies +
net financing for employees related stock purchase plans.
***
dollar amounts represent euro amounts converted at the average €-$
exchange rate for the period.
Net-debt-to-equity ratio
in millions of euros | Â | 6/30/2011 | Â | 3/31/2011 | Â | 6/30/2010 |
Current borrowings | 12,289 | 11,674 | 8,521 | |||
Net current financial assets | (2,737) | (1,709) | (1,225) | |||
Non-current financial debt | 20,410 | 20,215 | 22,813 | |||
Hedging instruments of non-current debt | (1,756) | (1,352) | (1,812) | |||
Cash and cash equivalents | (13,387) | (17,327) | (14,832) | |||
Net debt | 14,819 | 11,501 | 13,465 | |||
 |  |  |  | |||
Shareholders’ equity | 61,371 | 62,535 | 60,955 | |||
Estimated dividend payable | (1,248) | (3,832) | (2,547) | |||
Minority interests | 934 | 898 | 858 | |||
Equity | 61,057 | 59,601 | 59,266 | |||
 |  |  |  | |||
Net-debt-to-equity ratio | 24.3% | 19.3% | 22.7% |
2011 Sensitivities*
 |  | Scenario |  | Change |  | Impact on adjusted operating income(e) |  | Impact on adjusted net operating income(e) |
Dollar | 1.30 $/€ | +0.1 $ per € | -1.6 B€ | -0.8 B€ | ||||
Brent | 80 $/b | +1 $/b | +0.27 B€ / 0.35 B$ | +0.13 B€ / 0.17 B$ | ||||
European refining margins ERMI | 30 $/t | +1 $/t | +0.07 B€ / 0.09 B$ | +0.05 B€ / 0.07 B$ |
* sensitivities are revised once per year upon publication of the previous year’s fourth quarter results. The impact of the €-$ sensitivity on adjusted operating income and adjusted net operating income attributable to the Upstream segment are approximately 80% and 75% respectively, and the remaining impact of the €-$ sensitivity is essentially in the Downstream segment.
Return on average capital employed
in millions of euros | Â | Upstream | Â | Downstream | Â | Chemicals | Â | Segments | Â | Â | Group |
Adjusted net operating income | 9,729 | 1,003 | 911 | 11,643 | 11,450 | ||||||
Capital employed at 6/30/2010* | 43,908 | 16,010 | 7,286 | 67,204 | 72,042 | ||||||
Capital employed at 6/30/2011* | 46,671 | 14,921 | 7,938 | 69,530 | 72,843 | ||||||
ROACE | 21.5% | 6.5% | 12.0% | 17.0% | 15.8% |
* at replacement cost (excluding after-tax inventory effect).
in millions of euros | Â | Upstream | Â | Downstream | Â | Chemicals | Â | Segments | Â | Â | Group |
Adjusted net operating income | 9,475 | 1,289 | 938 | 11,702 | 11,599 | ||||||
Capital employed at 3/31/2010* | 39,925 | 15,634 | 7,412 | 62,971 | 67,099 | ||||||
Capital employed at 3/31/2011* | 44,528 | 14,527 | 7,681 | 66,736 | 70,579 | ||||||
ROACE | 22.4% | 8.5% | 12.4% | 18.0% | 16.8% |
* at replacement cost (excluding after-tax inventory effect).
in millions of euros | Â | Upstream | Â | Downstream | Â | Chemicals | Â | Segments | Â | Â | Group |
Adjusted net operating income | 8,597 | 1,168 | 857 | 10,622 | 10,748 | ||||||
Capital employed at 12/31/2009* | 37,397 | 15,299 | 6,898 | 59,594 | 64,451 | ||||||
Capital employed at 12/31/2010* | 43,972 | 15,561 | 7,312 | 66,845 | 70,866 | ||||||
ROACE | 21.1% | 7.6% | 12.1% | 16.8% | 15.9% |
* at replacement cost (excluding after-tax inventory effect).
Total financial statements
Second quarter 2011 consolidated accounts, IFRS
CONSOLIDATED STATEMENT OF INCOME | Â | Â | Â | |||
TOTAL | ||||||
(unaudited) | ||||||
 | ||||||
(M€) (a) |
2nd quarter
2011 |
1st quarter
2011 |
2nd quarter
2010 |
|||
Sales | 45,009 | 46,029 | 41,329 | |||
Excise taxes | (4,544) | (4,427) | (5,002) | |||
Revenues from sales | 40,465 | 41,602 | 36,327 | |||
Purchases, net of inventory variation | (28,386) | (27,255) | (23,929) | |||
Other operating expenses | (4,804) | (4,702) | (4,833) | |||
Exploration costs | (179) | (259) | (292) | |||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,531) | (1,686) | (1,757) | |||
Other income | 246 | 85 | 114 | |||
Other expense | (138) | (59) | (114) | |||
Financial interest on debt | (159) | (136) | (113) | |||
Financial income from marketable securities & cash equivalents | 55 | 47 | 24 | |||
Cost of net debt | (104) | (89) | (89) | |||
Other financial income | 335 | 75 | 142 | |||
Other financial expense | (104) | (108) | (95) | |||
Equity in income (loss) of affiliates | 444 | 506 | 513 | |||
Income taxes | (3,432) | (4,072) | (2,819) | |||
Consolidated net income | 2,812 | 4,038 | 3,168 | |||
Group share | 2,726 | 3,946 | 3,101 | |||
Minority interests | 86 | 92 | 67 | |||
Earnings per share (€) | 1.21 | 1.76 | 1.39 | |||
Fully-diluted earnings per share (€) | 1.21 | 1.75 | 1.38 | |||
(a) Except for per share amounts. |
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME | Â | Â | ||||
TOTAL | Â | |||||
(unaudited) | ||||||
 | ||||||
(M€) |
2nd quarter
2011 |
1st quarter
2011 |
2nd quarter
2010 |
|||
Consolidated net income | 2,812 | 4,038 | 3,168 | |||
Other comprehensive income | ||||||
Currency translation adjustment | (666) | (1,978) | 3,149 | |||
Available for sale financial assets | 315 | 115 | (49) | |||
Cash flow hedge | (11) | (24) | (75) | |||
Share of other comprehensive income of associates, net amount | (16) | (87) | 242 | |||
Other | (4) | 2 | 2 | |||
 | ||||||
Tax effect | (35) | 6 | 26 | |||
Total other comprehensive income (net amount) | (417) | (1,966) | 3,295 | |||
 |  |  |  | |||
Comprehensive income | 2,395 | 2,072 | 6,463 | |||
- Group share | 2,326 | 2,030 | 6,368 | |||
- Minority interests | 69 | 42 | 95 |
CONSOLIDATED STATEMENT OF INCOME | Â | Â | ||
TOTAL | ||||
(unaudited) | ||||
 | ||||
(M€) (a) |
1st half
2011 |
1st half
2010 |
||
Sales | 91,038 | 78,932 | ||
Excise taxes | (8,971) | (9,444) | ||
Revenues from sales | 82,067 | 69,488 | ||
Purchases, net of inventory variation | (55,641) | (45,630) | ||
Other operating expenses | (9,506) | (9,545) | ||
Exploration costs | (438) | (507) | ||
Depreciation, depletion and amortization of tangible assets and mineral interests | (3,217) | (3,456) | ||
Other income | 331 | 274 | ||
Other expense | (197) | (326) | ||
Financial interest on debt | (295) | (213) | ||
Financial income from marketable securities & cash equivalents | 102 | 48 | ||
Cost of net debt | (193) | (165) | ||
Other financial income | 410 | 213 | ||
Other financial expense | (212) | (190) | ||
Equity in income (loss) of affiliates | 950 | 1,037 | ||
Income taxes | (7,504) | (5,347) | ||
Consolidated net income | 6,850 | 5,846 | ||
Group share | 6,672 | 5,714 | ||
Minority interests | 178 | 132 | ||
Earnings per share (€) | 2.98 | 2.56 | ||
Fully-diluted earnings per share (€) | 2.96 | 2.55 | ||
(a) Except for per share amounts. |
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME | Â | |||
TOTAL | Â | |||
(unaudited) | ||||
 | ||||
(M€) |
1st half
2011 |
1st half
2010 |
||
Consolidated net income | 6,850 | 5,846 | ||
Other comprehensive income | ||||
Currency translation adjustment | (2,644) | 4,996 | ||
Available for sale financial assets | 430 | (52) | ||
Cash flow hedge | (35) | (51) | ||
Share of other comprehensive income of associates, net amount | (103) | 475 | ||
Other | (2) | 3 | ||
 | ||||
Tax effect | (29) | 18 | ||
Total other comprehensive income (net amount) | (2,383) | 5,389 | ||
 |  |  | ||
Comprehensive income | 4,467 | 11,235 | ||
- Group share | 4,356 | 11,044 | ||
- Minority interests | 111 | 191 |
CONSOLIDATED BALANCE SHEET | Â | Â | Â | Â | ||||
TOTAL | ||||||||
 | ||||||||
 | ||||||||
(M€) |
June 30, 2011
(unaudited) |
March 31, 2011
(unaudited) |
December 31, 2010 |
June 30, 2010
(unaudited) |
||||
ASSETS | ||||||||
Non-current assets | ||||||||
Intangible assets, net | 8,961 | 9,211 | 8,917 | 8,767 | ||||
Property, plant and equipment, net | 55,323 | 54,955 | 54,964 | 57,825 | ||||
Equity affiliates : investments and loans | 11,054 | 8,143 | 11,516 | 15,363 | ||||
Other investments | 5,287 | 4,458 | 4,590 | 1,220 | ||||
Hedging instruments of non-current financial debt | 1,756 | 1,352 | 1,870 | 1,812 | ||||
Other non-current assets | 3,727 | 3,466 | 3,655 | 3,437 | ||||
Total non-current assets | 86,108 | 81,585 | 85,512 | 88,424 | ||||
Current assets | ||||||||
Inventories, net | 15,950 | 15,516 | 15,600 | 15,130 | ||||
Accounts receivable, net | 18,267 | 19,758 | 18,159 | 18,193 | ||||
Other current assets | 8,474 | 8,766 | 7,483 | 8,289 | ||||
Current financial assets | 3,122 | 2,026 | 1,205 | 1,603 | ||||
Cash and cash equivalents | 13,387 | 17,327 | 14,489 | 14,832 | ||||
Total current assets | 59,200 | 63,393 | 56,936 | 58,047 | ||||
Assets classified as held for sale | 5,211 | 4,914 | 1,270 | - | ||||
Total assets | 150,519 | 149,892 | 143,718 | 146,471 | ||||
LIABILITIES & SHAREHOLDERS' EQUITY | ||||||||
Shareholders' equity | ||||||||
Common shares | 5,903 | 5,878 | 5,874 | 5,872 | ||||
Paid-in surplus and retained earnings | 64,148 | 64,677 | 60,538 | 58,274 | ||||
Currency translation adjustment | (5,177) | (4,517) | (2,495) | 381 | ||||
Treasury shares | (3,503) | (3,503) | (3,503) | (3,572) | ||||
Total shareholders' equity - Group Share | 61,371 | 62,535 | 60,414 | 60,955 | ||||
Minority interests | 934 | 898 | 857 | 858 | ||||
Total shareholders' equity | 62,305 | 63,433 | 61,271 | 61,813 | ||||
Non-current liabilities | ||||||||
Deferred income taxes | 9,619 | 10,204 | 9,947 | 10,328 | ||||
Employee benefits | 2,111 | 2,103 | 2,171 | 2,181 | ||||
Provisions and other non-current liabilities | 8,419 | 8,584 | 9,098 | 9,418 | ||||
Total non-current liabilities | 20,149 | 20,891 | 21,216 | 21,927 | ||||
Non-current financial debt | 20,410 | 20,215 | 20,783 | 22,813 | ||||
Current liabilities | ||||||||
Accounts payable | 18,395 | 18,383 | 18,450 | 17,557 | ||||
Other creditors and accrued liabilities | 16,191 | 14,812 | 11,989 | 13,462 | ||||
Current borrowings | 12,289 | 11,674 | 9,653 | 8,521 | ||||
Other current financial liabilities | 385 | 317 | 159 | 378 | ||||
Total current liabilities | 47,260 | 45,186 | 40,251 | 39,918 | ||||
Liabilities directly associated with the assets classified as held for sale | 395 | 167 | 197 | - | ||||
Total liabilities and shareholders' equity | 150,519 | 149,892 | 143,718 | 146,471 |
CONSOLIDATED STATEMENT OF CASH FLOW | Â | Â | Â | |||
TOTAL | ||||||
(unaudited) | ||||||
 | ||||||
(M€) |
2nd quarter
2011 |
1st quarter
2011 |
2nd quarter
2010 |
|||
CASH FLOW FROM OPERATING ACTIVITIES | ||||||
Consolidated net income | 2,812 | 4,038 | 3,168 | |||
Depreciation, depletion and amortization | 1,641 | 1,888 | 1,996 | |||
Non-current liabilities, valuation allowances and deferred taxes | 283 | 565 | 239 | |||
Impact of coverage of pension benefit plans | - | - | - | |||
(Gains) losses on sales of assets | (229) | (6) | (24) | |||
Undistributed affiliates' equity earnings | 59 | (182) | 79 | |||
(Increase) decrease in working capital | 476 | (587) | (522) | |||
Other changes, net | 22 | (2) | 6 | |||
Cash flow from operating activities | 5,064 | 5,714 | 4,942 | |||
CASH FLOW USED IN INVESTING ACTIVITIES | ||||||
Intangible assets and property, plant and equipment additions | (3,215) | (5,374) | (2,958) | |||
Acquisitions of subsidiaries, net of cash acquired | (979) | - | - | |||
Investments in equity affiliates and other securities | (3,071) | (150) | (244) | |||
Increase in non-current loans | (305) | (159) | (244) | |||
Total expenditures | (7,570) | (5,683) | (3,446) | |||
Proceeds from disposal of intangible assets and property, plant and equipment | 620 | 6 | 89 | |||
Proceeds from disposal of subsidiaries, net of cash sold | 171 | - | 321 | |||
Proceeds from disposal of non-current investments | 452 | 290 | 348 | |||
Repayment of non-current loans | 95 | 367 | 92 | |||
Total divestments | 1,338 | 663 | 850 | |||
Cash flow used in investing activities | (6,232) | (5,020) | (2,596) | |||
CASH FLOW USED IN FINANCING ACTIVITIES | ||||||
Issuance (repayment) of shares: | ||||||
- Parent company shareholders | 354 | 50 | 6 | |||
- Treasury shares | - | - | 31 | |||
- Minority shareholders | - | - | - | |||
Dividends paid: | ||||||
- Parent company shareholders | (2,572) | - | (2,548) | |||
- Minority shareholders | (61) | (1) | (82) | |||
Other transactions with minority shareholders | 59 | - | (450) | |||
Net issuance (repayment) of non-current debt | 678 | 2,228 | 1,979 | |||
Increase (decrease) in current borrowings | (200) | 488 | 977 | |||
Increase (decrease) in current financial assets and liabilities | (1,123) | (511) | (453) | |||
Cash flow used in financing activities | (2,865) | 2,254 | (540) | |||
Net increase (decrease) in cash and cash equivalents | (4,033) | 2,948 | 1,806 | |||
Effect of exchange rates | 93 | (110) | 72 | |||
Cash and cash equivalents at the beginning of the period | 17,327 | 14,489 | 12,954 | |||
Cash and cash equivalents at the end of the period | 13,387 | 17,327 | 14,832 |
CONSOLIDATED STATEMENT OF CASH FLOW | Â | Â | ||
TOTAL | ||||
(unaudited) | ||||
 | ||||
(M€) |
1st half
2011 |
1st half
2010 |
||
CASH FLOW FROM OPERATING ACTIVITIES | ||||
Consolidated net income | 6,850 | 5,846 | ||
Depreciation, depletion and amortization | 3,529 | 3,867 | ||
Non-current liabilities, valuation allowances and deferred taxes | 848 | 294 | ||
Impact of coverage of pension benefit plans | - | - | ||
(Gains) losses on sales of assets | (235) | (172) | ||
Undistributed affiliates' equity earnings | (123) | (183) | ||
(Increase) decrease in working capital | (111) | 513 | ||
Other changes, net | 20 | 37 | ||
Cash flow from operating activities | 10,778 | 10,202 | ||
CASH FLOW USED IN INVESTING ACTIVITIES | ||||
Intangible assets and property, plant and equipment additions | (8,589) | (6,422) | ||
Acquisitions of subsidiaries, net of cash acquired | (979) | - | ||
Investments in equity affiliates and other securities | (3,221) | (313) | ||
Increase in non-current loans | (464) | (420) | ||
Total expenditures | (13,253) | (7,155) | ||
Proceeds from disposal of intangible assets and property, plant and equipment | 626 | 123 | ||
Proceeds from disposal of subsidiaries, net of cash sold | 171 | 321 | ||
Proceeds from disposal of non-current investments | 742 | 1,279 | ||
Repayment of non-current loans | 462 | 175 | ||
Total divestments | 2,001 | 1,898 | ||
Cash flow used in investing activities | (11,252) | (5,257) | ||
CASH FLOW USED IN FINANCING ACTIVITIES | ||||
Issuance (repayment) of shares: | ||||
- Parent company shareholders | 404 | 11 | ||
- Treasury shares | - | 49 | ||
- Minority shareholders | - | - | ||
Dividends paid: | ||||
- Parent company shareholders | (2,572) | (2,548) | ||
- Minority shareholders | (62) | (82) | ||
Other transactions with minority shareholders | 59 | (450) | ||
Net issuance (repayment) of non-current debt | 2,906 | 2,042 | ||
Increase (decrease) in current borrowings | 288 | 376 | ||
Increase (decrease) in current financial assets and liabilities | (1,634) | (950) | ||
Cash flow used in financing activities | (611) | (1,552) | ||
Net increase (decrease) in cash and cash equivalents | (1,085) | 3,393 | ||
Effect of exchange rates | (17) | (223) | ||
Cash and cash equivalents at the beginning of the period | 14,489 | 11,662 | ||
Cash and cash equivalents at the end of the period | 13,387 | 14,832 |
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY | Â | Â | Â | Â | ||||||||||||||
TOTAL | Â | Â | Â | Â | Â | |||||||||||||
(unaudited) | Â | Â | Â | Â | Â | Â | Â | Â | Â | |||||||||
Common shares issued | Paid-in surplus and retained earnings | Currency translation adjustment | Treasury shares | Shareholders' equity Group Share | Minority interests | Total shareholders' equity | ||||||||||||
(M€) | Number | Amount |  |  | Number | Amount |  |  |  | |||||||||
As of January 1, 2010 | 2,348,422,884 | 5,871 | 55,372 | (5,069) | (115,407,190) | (3,622) | 52,552 | 987 | 53,539 | |||||||||
Net income of the first half | - | - | 5,714 | - | - | - | 5,714 | 132 | 5,846 | |||||||||
Other comprehensive Income | - | - | (130) | 5,460 | - | - | 5,330 | 59 | 5,389 | |||||||||
Comprehensive Income | - | - | 5,584 | 5,460 | - | - | 11,044 | 191 | 11,235 | |||||||||
Dividend | - | - | (2,548) | - | - | - | (2,548) | (82) | (2,630) | |||||||||
Issuance of common shares | 306,577 | 1 | 10 | - | - | - | 11 | - | 11 | |||||||||
Purchase of treasury shares | - | - | - | - | - | - | - | - | - | |||||||||
Sale of treasury shares (1) | - | - | (1) | - | 1,258,812 | 50 | 49 | - | 49 | |||||||||
Share-based payments | - | - | 59 | - | - | - | 59 | - | 59 | |||||||||
Share cancellation | - | - | - | - | - | - | - | - | - | |||||||||
Other operations with minority interests | - | - | (202) | (10) | - | - | (212) | (238) | (450) | |||||||||
Other items | - | - | - | - | - | - | - | - | - | |||||||||
As of June 30, 2010 | 2,348,729,461 | 5,872 | 58,274 | 381 | (114,148,378) | (3,572) | 60,955 | 858 | 61,813 | |||||||||
Net income from July 1 to December 31, 2010 | - | - | 4,857 | - | - | - | 4,857 | 104 | 4,961 | |||||||||
Other comprehensive Income | - | - | (86) | (2,879) | - | - | (2,965) | (50) | (3,015) | |||||||||
Comprehensive Income | - | - | 4,771 | (2,879) | - | - | 1,892 | 54 | 1,946 | |||||||||
Dividend | - | - | (2,550) | - | - | - | (2,550) | (70) | (2,620) | |||||||||
Issuance of common shares | 911,470 | 2 | 28 | - | - | - | 30 | - | 30 | |||||||||
Purchase of treasury shares | - | - | - | - | - | - | - | - | - | |||||||||
Sale of treasury shares (1) | - | - | (69) | - | 1,660,699 | 69 | - | - | - | |||||||||
Share-based payments | - | - | 81 | - | - | - | 81 | - | 81 | |||||||||
Share cancellation | - | - | - | - | - | - | - | - | - | |||||||||
Other operations with minority interests | - | - | 3 | 3 | - | - | 6 | 15 | 21 | |||||||||
Other items | - | - | - | - | - | - | - | - | - | |||||||||
As of December 31, 2010 | 2,349,640,931 | 5,874 | 60,538 | (2,495) | (112,487,679) | (3,503) | 60,414 | 857 | 61,271 | |||||||||
Net income of the first half | - | - | 6,672 | - | - | - | 6,672 | 178 | 6,850 | |||||||||
Other comprehensive Income | - | - | 368 | (2,684) | - | - | (2,316) | (67) | (2,383) | |||||||||
Comprehensive Income | - | - | 7,040 | (2,684) | - | - | 4,356 | 111 | 4,467 | |||||||||
Dividend | - | - | (3,888) | - | - | - | (3,888) | (62) | (3,950) | |||||||||
Issuance of common shares | 11,749,578 | 29 | 375 | - | - | - | 404 | - | 404 | |||||||||
Purchase of treasury shares | - | - | - | - | - | - | - | - | - | |||||||||
Sale of treasury shares (1) | - | - | - | - | 3,804 | - | - | - | - | |||||||||
Share-based payments | - | - | 83 | - | - | - | 83 | - | 83 | |||||||||
Share cancellation | - | - | - | - | - | - | - | - | - | |||||||||
Other operations with minority interests | - | - | - | 2 | - | - | 2 | 57 | 59 | |||||||||
Other items | - | - | - | - | - | - | - | (29) | (29) | |||||||||
As of June 30, 2011 | 2,361,390,509 | 5,903 | 64,148 | (5,177) | (112,483,875) | (3,503) | 61,371 | 934 | 62,305 | |||||||||
 | ||||||||||||||||||
(1) Treasury shares related to the stock option purchase plans and restricted stock grants |
BUSINESS SEGMENT INFORMATION | Â | Â | Â | Â | Â | Â | ||||||
TOTAL | ||||||||||||
(unaudited) | ||||||||||||
 |  |  |  |  |  |  | ||||||
2nd quarter 2011
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 5,166 | 34,551 | 5,291 | 1 | - | 45,009 | ||||||
Intersegment sales | 6,341 | 1,535 | 345 | 43 | (8,264) | - | ||||||
Excise taxes | - | (4,544) | - | - | - | (4,544) | ||||||
Revenues from sales | 11,507 | 31,542 | 5,636 | 44 | (8,264) | 40,465 | ||||||
Operating expenses | (5,072) | (31,149) | (5,251) | (161) | 8,264 | (33,369) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,100) | (300) | (122) | (9) | - | (1,531) | ||||||
Operating income | 5,335 | 93 | 263 | (126) | - | 5,565 | ||||||
Equity in income (loss) of affiliates and other items | 473 | 37 | 18 | 255 | - | 783 | ||||||
Tax on net operating income | (3,275) | (20) | (117) | (53) | - | (3,465) | ||||||
Net operating income | 2,533 | 110 | 164 | 76 | - | 2,883 | ||||||
Net cost of net debt | (71) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (86) | ||||||
Net income | 2,726 | |||||||||||
 |  |  |  |  |  |  | ||||||
2nd quarter 2011 (adjustments) (a)
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | (55) | - | - | - | (55) | |||||||
Intersegment sales | ||||||||||||
Excise taxes | Â | Â | Â | Â | Â | Â | ||||||
Revenues from sales | (55) | - | - | - | (55) | |||||||
Operating expenses | - | (135) | (15) | - | (150) | |||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | - | - | - | - | Â | - | ||||||
Operating income (b) | (55) | (135) | (15) | - | (205) | |||||||
Equity in income (loss) of affiliates and other items | 121 | (2) | (37) | 43 | 125 | |||||||
Tax on net operating income | 10 | 50 | (31) | (2) | Â | 27 | ||||||
Net operating income (b) | 76 | (87) | (83) | 41 | (53) | |||||||
Net cost of net debt | - | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (15) | ||||||
Net income | (68) | |||||||||||
 | ||||||||||||
(a) Adjustments include special items, inventory valuation effect
and, as from January 1st, 2011, the effect
of changes in fair value.
 (b) Of which inventory valuation effect |
||||||||||||
On operating income | - | (72) | (15) | - | ||||||||
On net operating income | - | (42) | (17) | - | ||||||||
 |
 |
 |
 |
 |
 |  | ||||||
2nd quarter 2011 (adjusted)
(M€) (a) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 5,221 | 34,551 | 5,291 | 1 | - | 45,064 | ||||||
Intersegment sales | 6,341 | 1,535 | 345 | 43 | (8,264) | - | ||||||
Excise taxes | - | (4,544) | - | - | - | (4,544) | ||||||
Revenues from sales | 11,562 | 31,542 | 5,636 | 44 | (8,264) | 40,520 | ||||||
Operating expenses | (5,072) | (31,014) | (5,236) | (161) | 8,264 | (33,219) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,100) | (300) | (122) | (9) | - | (1,531) | ||||||
Adjusted operating income | 5,390 | 228 | 278 | (126) | - | 5,770 | ||||||
Equity in income (loss) of affiliates and other items | 352 | 39 | 55 | 212 | - | 658 | ||||||
Tax on net operating income | (3,285) | (70) | (86) | (51) | - | (3,492) | ||||||
Adjusted net operating income | 2,457 | 197 | 247 | 35 | - | 2,936 | ||||||
Net cost of net debt | (71) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (71) | ||||||
Ajusted net income | Â | Â | Â | Â | Â | 2,794 | ||||||
Adjusted fully-diluted earnings per share (€) |  |  |  |  |  | 1.24 | ||||||
(a) Except for per share amounts. | ||||||||||||
 |  |  |  |  |  |  | ||||||
2nd quarter 2011
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Total expenditures | 6,868 | 462 | 209 | 31 | 7,570 | |||||||
Total divestments | 921 | 28 | 12 | 377 | 1,338 | |||||||
Cash flow from operating activities | 5,605 | 7 | 138 | (686) | Â | 5,064 |
BUSINESS SEGMENT INFORMATION | Â | Â | Â | Â | Â | Â | ||||||
TOTAL | ||||||||||||
(unaudited) | ||||||||||||
 |  |  |  |  |  |  | ||||||
1st quarter 2011
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 6,144 | 34,769 | 5,105 | 11 | - | 46,029 | ||||||
Intersegment sales | 6,939 | 1,582 | 297 | 41 | (8,859) | - | ||||||
Excise taxes | - | (4,427) | - | - | - | (4,427) | ||||||
Revenues from sales | 13,083 | 31,924 | 5,402 | 52 | (8,859) | 41,602 | ||||||
Operating expenses | (5,938) | (30,093) | (4,891) | (153) | 8,859 | (32,216) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,240) | (319) | (119) | (8) | - | (1,686) | ||||||
Operating income | 5,905 | 1,512 | 392 | (109) | - | 7,700 | ||||||
Equity in income (loss) of affiliates and other items | 343 | 59 | 82 | 15 | - | 499 | ||||||
Tax on net operating income | (3,527) | (451) | (124) | - | - | (4,102) | ||||||
Net operating income | 2,721 | 1,120 | 350 | (94) | - | 4,097 | ||||||
Net cost of net debt | (59) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (92) | ||||||
Net income | 3,946 | |||||||||||
 |  |  |  |  |  |  | ||||||
1st quarter 2011 (adjustments) (a)
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 84 | - | - | - | 84 | |||||||
Intersegment sales | ||||||||||||
Excise taxes | Â | Â | Â | Â | Â | Â | ||||||
Revenues from sales | 84 | - | - | - | 84 | |||||||
Operating expenses | - | 1,226 | 130 | - | 1,356 | |||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | - | - | - | - | Â | - | ||||||
Operating income (b) | 84 | 1,226 | 130 | - | 1,440 | |||||||
Equity in income (loss) of affiliates and other items | - | 14 | 25 | 11 | 50 | |||||||
Tax on net operating income | (212) | (396) | (43) | - | Â | (651) | ||||||
Net operating income (b) | (128) | 844 | 112 | 11 | 839 | |||||||
Net cost of net debt | - | |||||||||||
Minority interests | Â | Â | Â | Â | Â | 3 | ||||||
Net income | 842 | |||||||||||
 | ||||||||||||
(a) Adjustments include special items, inventory valuation effect
and, as from January 1st, 2011, the effect
of changes in fair value.
 (b) Of which inventory valuation effect |
||||||||||||
On operating income | - | 1,226 | 130 | - | ||||||||
On net operating income | - | 844 | 112 | - | ||||||||
 |
 |
 |
 |
 |
 |  | ||||||
1st quarter 2011 (adjusted)
(M€) (a) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 6,060 | 34,769 | 5,105 | 11 | - | 45,945 | ||||||
Intersegment sales | 6,939 | 1,582 | 297 | 41 | (8,859) | - | ||||||
Excise taxes | - | (4,427) | - | - | - | (4,427) | ||||||
Revenues from sales | 12,999 | 31,924 | 5,402 | 52 | (8,859) | 41,518 | ||||||
Operating expenses | (5,938) | (31,319) | (5,021) | (153) | 8,859 | (33,572) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,240) | (319) | (119) | (8) | - | (1,686) | ||||||
Adjusted operating income | 5,821 | 286 | 262 | (109) | - | 6,260 | ||||||
Equity in income (loss) of affiliates and other items | 343 | 45 | 57 | 4 | - | 449 | ||||||
Tax on net operating income | (3,315) | (55) | (81) | - | - | (3,451) | ||||||
Adjusted net operating income | 2,849 | 276 | 238 | (105) | - | 3,258 | ||||||
Net cost of net debt | (59) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (95) | ||||||
Ajusted net income | Â | Â | Â | Â | Â | 3,104 | ||||||
Adjusted fully-diluted earnings per share (€) |  |  |  |  |  | 1.38 | ||||||
(a) Except for per share amounts. | ||||||||||||
 |  |  |  |  |  |  | ||||||
1st quarter 2011
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Total expenditures | 5,232 | 264 | 171 | 16 | - | 5,683 | ||||||
Total divestments | 335 | 23 | 14 | 291 | - | 663 | ||||||
Cash flow from operating activities | 4,643 | 1,158 | (144) | 57 | - | 5,714 |
BUSINESS SEGMENT INFORMATION | Â | Â | Â | Â | Â | Â | ||||||
TOTAL | ||||||||||||
(unaudited) | ||||||||||||
 |  |  |  |  |  |  | ||||||
2nd quarter 2010
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 4,546 | 32,190 | 4,589 | 4 | - | 41,329 | ||||||
Intersegment sales | 5,717 | 1,394 | 270 | 45 | (7,426) | - | ||||||
Excise taxes | - | (5,002) | - | - | - | (5,002) | ||||||
Revenues from sales | 10,263 | 28,582 | 4,859 | 49 | (7,426) | 36,327 | ||||||
Operating expenses | (4,364) | (27,460) | (4,483) | (173) | 7,426 | (29,054) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,292) | (318) | (136) | (11) | - | (1,757) | ||||||
Operating income | 4,607 | 804 | 240 | (135) | - | 5,516 | ||||||
Equity in income (loss) of affiliates and other items | 190 | 124 | 78 | 168 | - | 560 | ||||||
Tax on net operating income | (2,621) | (250) | (65) | 85 | - | (2,851) | ||||||
Net operating income | 2,176 | 678 | 253 | 118 | - | 3,225 | ||||||
Net cost of net debt | (57) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (67) | ||||||
Net income | 3,101 | |||||||||||
 |  |  |  |  |  |  | ||||||
2nd quarter 2010 (adjustments) (a)
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | ||||||||||||
Intersegment sales | ||||||||||||
Excise taxes | Â | Â | Â | Â | Â | Â | ||||||
Revenues from sales | ||||||||||||
Operating expenses | - | 255 | (57) | - | 198 | |||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | - | - | (8) | - | Â | (8) | ||||||
Operating income (b) | - | 255 | (65) | - | 190 | |||||||
Equity in income (loss) of affiliates and other items (c) | (40) | 25 | 18 | (7) | (4) | |||||||
Tax on net operating income | 13 | (85) | 26 | - | Â | (46) | ||||||
Net operating income (b) | (27) | 195 | (21) | (7) | 140 | |||||||
Net cost of net debt | - | |||||||||||
Minority interests | Â | Â | Â | Â | Â | - | ||||||
Net income | 140 | |||||||||||
 | ||||||||||||
(a) Adjustments include special items, inventory valuation effect
and, until June 30,2010, equity share of adjustments related to
Sanofi-Aventis.
 (b) Of which inventory valuation effect |
||||||||||||
On operating income | - | 255 | (41) | - | ||||||||
On net operating income | - | 195 | (25) | - | ||||||||
(c) Of which equity share of adjustments related to Sanofi-Aventis | - | - | - | (40) | ||||||||
 |  |  |  |  |  |  | ||||||
2nd quarter 2010 (adjusted)
(M€) (a) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 4,546 | 32,190 | 4,589 | 4 | - | 41,329 | ||||||
Intersegment sales | 5,717 | 1,394 | 270 | 45 | (7,426) | - | ||||||
Excise taxes | - | (5,002) | - | - | - | (5,002) | ||||||
Revenues from sales | 10,263 | 28,582 | 4,859 | 49 | (7,426) | 36,327 | ||||||
Operating expenses | (4,364) | (27,715) | (4,426) | (173) | 7,426 | (29,252) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,292) | (318) | (128) | (11) | - | (1,749) | ||||||
Adjusted operating income | 4,607 | 549 | 305 | (135) | - | 5,326 | ||||||
Equity in income (loss) of affiliates and other items | 230 | 99 | 60 | 175 | - | 564 | ||||||
Tax on net operating income | (2,634) | (165) | (91) | 85 | - | (2,805) | ||||||
Adjusted net operating income | 2,203 | 483 | 274 | 125 | - | 3,085 | ||||||
Net cost of net debt | (57) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (67) | ||||||
Ajusted net income | Â | Â | Â | Â | Â | 2,961 | ||||||
Adjusted fully-diluted earnings per share (€) |  |  |  |  |  | 1.32 | ||||||
(a) Except for per share amounts. | ||||||||||||
 |  |  |  |  |  |  | ||||||
2nd quarter 2010
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Total expenditures | 2,723 | 562 | 144 | 17 | 3,446 | |||||||
Total divestments | 174 | 11 | 328 | 337 | 850 | |||||||
Cash flow from operating activities | 4,154 | 1,042 | 477 | (731) | Â | 4,942 |
BUSINESS SEGMENT INFORMATION | Â | Â | Â | Â | Â | Â | ||||||
TOTAL | ||||||||||||
(unaudited) | ||||||||||||
 |  |  |  |  |  |  | ||||||
1st half 2011
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 11,310 | 69,320 | 10,396 | 12 | - | 91,038 | ||||||
Intersegment sales | 13,280 | 3,117 | 642 | 84 | (17,123) | - | ||||||
Excise taxes | - | (8,971) | - | - | - | (8,971) | ||||||
Revenues from sales | 24,590 | 63,466 | 11,038 | 96 | (17,123) | 82,067 | ||||||
Operating expenses | (11,010) | (61,242) | (10,142) | (314) | 17,123 | (65,585) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (2,340) | (619) | (241) | (17) | - | (3,217) | ||||||
Operating income | 11,240 | 1,605 | 655 | (235) | - | 13,265 | ||||||
Equity in income (loss) of affiliates and other items | 816 | 96 | 100 | 270 | - | 1,282 | ||||||
Tax on net operating income | (6,802) | (471) | (241) | (53) | - | (7,567) | ||||||
Net operating income | 5,254 | 1,230 | 514 | (18) | - | 6,980 | ||||||
Net cost of net debt | (130) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (178) | ||||||
Net income | 6,672 | |||||||||||
 |  |  |  |  |  |  | ||||||
1st half 2011 (adjustments) (a)
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 29 | - | - | - | 29 | |||||||
Intersegment sales | ||||||||||||
Excise taxes | Â | Â | Â | Â | Â | Â | ||||||
Revenues from sales | 29 | - | - | - | 29 | |||||||
Operating expenses | - | 1,091 | 115 | - | 1,206 | |||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | - | - | - | - | Â | - | ||||||
Operating income (b) | 29 | 1,091 | 115 | - | 1,235 | |||||||
Equity in income (loss) of affiliates and other items | 121 | 12 | (12) | 54 | 175 | |||||||
Tax on net operating income | (202) | (346) | (74) | (2) | Â | (624) | ||||||
Net operating income (b) | (52) | 757 | 29 | 52 | 786 | |||||||
Net cost of net debt | - | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (12) | ||||||
Net income | 774 | |||||||||||
 | ||||||||||||
(a) Adjustments include special items, inventory valuation effect
and, as from January 1st, 2011, the effect
of changes in fair value.
 (b) Of which inventory valuation effect |
||||||||||||
On operating income | - | 1,154 | 115 | - | ||||||||
On net operating income | - | 802 | 95 | - | ||||||||
 |
 |
 |
 |
 |
 |  | ||||||
1st half 2011 (adjusted)
(M€) (a) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 11,281 | 69,320 | 10,396 | 12 | - | 91,009 | ||||||
Intersegment sales | 13,280 | 3,117 | 642 | 84 | (17,123) | - | ||||||
Excise taxes | - | (8,971) | - | - | - | (8,971) | ||||||
Revenues from sales | 24,561 | 63,466 | 11,038 | 96 | (17,123) | 82,038 | ||||||
Operating expenses | (11,010) | (62,333) | (10,257) | (314) | 17,123 | (66,791) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (2,340) | (619) | (241) | (17) | - | (3,217) | ||||||
Adjusted operating income | 11,211 | 514 | 540 | (235) | - | 12,030 | ||||||
Equity in income (loss) of affiliates and other items | 695 | 84 | 112 | 216 | - | 1,107 | ||||||
Tax on net operating income | (6,600) | (125) | (167) | (51) | - | (6,943) | ||||||
Adjusted net operating income | 5,306 | 473 | 485 | (70) | - | 6,194 | ||||||
Net cost of net debt | (130) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (166) | ||||||
Ajusted net income | Â | Â | Â | Â | Â | 5,898 | ||||||
Adjusted fully-diluted earnings per share (€) |  |  |  |  |  | 2.62 | ||||||
(a) Except for per share amounts. | ||||||||||||
 |  |  |  |  |  |  | ||||||
1st half 2011
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Total expenditures | 12,100 | 726 | 380 | 47 | 13,253 | |||||||
Total divestments | 1,256 | 51 | 26 | 668 | 2,001 | |||||||
Cash flow from operating activities | 10,248 | 1,165 | (6) | (629) | Â | 10,778 |
BUSINESS SEGMENT INFORMATION | Â | Â | Â | Â | Â | Â | ||||||
TOTAL | ||||||||||||
(unaudited) | ||||||||||||
 |  |  |  |  |  |  | ||||||
1st half 2010
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 9,115 | 60,998 | 8,812 | 7 | - | 78,932 | ||||||
Intersegment sales | 11,019 | 2,475 | 507 | 87 | (14,088) | - | ||||||
Excise taxes | - | (9,444) | - | - | - | (9,444) | ||||||
Revenues from sales | 20,134 | 54,029 | 9,319 | 94 | (14,088) | 69,488 | ||||||
Operating expenses | (8,818) | (52,081) | (8,553) | (318) | 14,088 | (55,682) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (2,548) | (623) | (266) | (19) | - | (3,456) | ||||||
Operating income | 8,768 | 1,325 | 500 | (243) | - | 10,350 | ||||||
Equity in income (loss) of affiliates and other items | 298 | 155 | 123 | 432 | - | 1,008 | ||||||
Tax on net operating income | (4,995) | (414) | (138) | 142 | - | (5,405) | ||||||
Net operating income | 4,071 | 1,066 | 485 | 331 | - | 5,953 | ||||||
Net cost of net debt | (107) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (132) | ||||||
Net income | 5,714 | |||||||||||
 |  |  |  |  |  |  | ||||||
1st half 2010 (adjustments) (a)
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | ||||||||||||
Intersegment sales | ||||||||||||
Excise taxes | Â | Â | Â | Â | Â | Â | ||||||
Revenues from sales | ||||||||||||
Operating expenses | - | 585 | 49 | - | 634 | |||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | - | - | (8) | - | Â | (8) | ||||||
Operating income (b) | - | 585 | 41 | - | 626 | |||||||
Equity in income (loss) of affiliates and other items (c) | (146) | 41 | 22 | 84 | 1 | |||||||
Tax on net operating income | 43 | (198) | (9) | (2) | Â | (166) | ||||||
Net operating income (b) | (103) | 428 | 54 | 82 | 461 | |||||||
Net cost of net debt | - | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (4) | ||||||
Net income | 457 | |||||||||||
 | ||||||||||||
(a) Adjustments include special items, inventory valuation effect
and, until June 30,2010, equity share of adjustments related to
Sanofi-Aventis.
 (b) Of which inventory valuation effect |
||||||||||||
On operating income | - | 635 | 65 | - | ||||||||
On net operating income | - | 467 | 50 | - | ||||||||
(c) Of which equity share of adjustments related to Sanofi-Aventis | - | - | - | (81) | ||||||||
 |  |  |  |  |  |  | ||||||
1st half 2010 (adjusted)
(M€) (a) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Non-Group sales | 9,115 | 60,998 | 8,812 | 7 | - | 78,932 | ||||||
Intersegment sales | 11,019 | 2,475 | 507 | 87 | (14,088) | - | ||||||
Excise taxes | - | (9,444) | - | - | - | (9,444) | ||||||
Revenues from sales | 20,134 | 54,029 | 9,319 | 94 | (14,088) | 69,488 | ||||||
Operating expenses | (8,818) | (52,666) | (8,602) | (318) | 14,088 | (56,316) | ||||||
Depreciation, depletion and amortization of tangible assets and mineral interests | (2,548) | (623) | (258) | (19) | - | (3,448) | ||||||
Adjusted operating income | 8,768 | 740 | 459 | (243) | - | 9,724 | ||||||
Equity in income (loss) of affiliates and other items | 444 | 114 | 101 | 348 | - | 1,007 | ||||||
Tax on net operating income | (5,038) | (216) | (129) | 144 | - | (5,239) | ||||||
Adjusted net operating income | 4,174 | 638 | 431 | 249 | - | 5,492 | ||||||
Net cost of net debt | (107) | |||||||||||
Minority interests | Â | Â | Â | Â | Â | (128) | ||||||
Ajusted net income | Â | Â | Â | Â | Â | 5,257 | ||||||
Adjusted fully-diluted earnings per share (€) |  |  |  |  |  | 2.34 | ||||||
(a) Except for per share amounts. | ||||||||||||
 |  |  |  |  |  |  | ||||||
1st half 2010
(M€) |
Upstream | Downstream | Chemicals | Corporate | Intercompany | Total | ||||||
Total expenditures | 5,866 | 1,018 | 238 | 33 | 7,155 | |||||||
Total divestments | 261 | 38 | 334 | 1,265 | 1,898 | |||||||
Cash flow from operating activities | 8,834 | 1,496 | 387 | (515) | Â | 10,202 |
CONSOLIDATED STATEMENT OF INCOME (Impact of adjustments) | Â | Â | ||||
TOTAL | Â | |||||
(unaudited) | ||||||
 | ||||||
2nd quarter 2011
(M€) |
Adjusted | Adjustments | Consolidated statement of income | |||
Sales | 45,064 | (55) | 45,009 | |||
Excise taxes | (4,544) | - | (4,544) | |||
Revenues from sales | 40,520 | (55) | 40,465 | |||
Purchases net of inventory variation | (28,299) | (87) | (28,386) | |||
Other operating expenses | (4,741) | (63) | (4,804) | |||
Exploration costs | (179) | - | (179) | |||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,531) | - | (1,531) | |||
Other income | 35 | 211 | 246 | |||
Other expense | (70) | (68) | (138) | |||
Financial interest on debt | (159) | - | (159) | |||
Financial income from marketable securities & cash equivalents | 55 | - | 55 | |||
Cost of net debt | (104) | - | (104) | |||
Other financial income | 335 | - | 335 | |||
Other financial expense | (104) | - | (104) | |||
Equity in income (loss) of affiliates | 462 | (18) | 444 | |||
Income taxes | (3,459) | 27 | (3,432) | |||
Consolidated net income | 2,865 | (53) | 2,812 | |||
Group share | 2,794 | (68) | 2,726 | |||
Minority interests | 71 | 15 | 86 | |||
 | ||||||
 | ||||||
2nd quarter 2010
(M€) |
Adjusted | Adjustments | Consolidated statement of income | |||
Sales | 41,329 | - | 41,329 | |||
Excise taxes | (5,002) | - | (5,002) | |||
Revenues from sales | 36,327 | - | 36,327 | |||
Purchases net of inventory variation | (24,143) | 214 | (23,929) | |||
Other operating expenses | (4,817) | (16) | (4,833) | |||
Exploration costs | (292) | - | (292) | |||
Depreciation, depletion and amortization of tangible assets and mineral interests | (1,749) | (8) | (1,757) | |||
Other income | 52 | 62 | 114 | |||
Other expense | (61) | (53) | (114) | |||
Financial interest on debt | (113) | - | (113) | |||
Financial income from marketable securities & cash equivalents | 24 | - | 24 | |||
Cost of net debt | (89) | - | (89) | |||
Other financial income | 142 | - | 142 | |||
Other financial expense | (95) | - | (95) | |||
Equity in income (loss) of affiliates | 526 | (13) | 513 | |||
Income taxes | (2,773) | (46) | (2,819) | |||
Consolidated net income | 3,028 | 140 | 3,168 | |||
Group share | 2,961 | 140 | 3,101 | |||
Minority interests | 67 | - | 67 |
CONSOLIDATED STATEMENT OF INCOME (Impact of adjustments) | Â | Â | ||||
TOTAL | Â | |||||
(unaudited) | ||||||
 | ||||||
1st half 2011
(M€) |
Adjusted | Adjustments | Consolidated statement of income | |||
Sales | 91,009 | 29 | 91,038 | |||
Excise taxes | (8,971) | - | (8,971) | |||
Revenues from sales | 82,038 | 29 | 82,067 | |||
Purchases net of inventory variation | (56,910) | 1,269 | (55,641) | |||
Other operating expenses | (9,443) | (63) | (9,506) | |||
Exploration costs | (438) | - | (438) | |||
Depreciation, depletion and amortization of tangible assets and mineral interests | (3,217) | - | (3,217) | |||
Other income | 109 | 222 | 331 | |||
Other expense | (129) | (68) | (197) | |||
Financial interest on debt | (295) | - | (295) | |||
Financial income from marketable securities & cash equivalents | 102 | - | 102 | |||
Cost of net debt | (193) | - | (193) | |||
Other financial income | 410 | - | 410 | |||
Other financial expense | (212) | - | (212) | |||
Equity in income (loss) of affiliates | 929 | 21 | 950 | |||
Income taxes | (6,880) | (624) | (7,504) | |||
Consolidated net income | 6,064 | 786 | 6,850 | |||
Group share | 5,898 | 774 | 6,672 | |||
Minority interests | 166 | 12 | 178 | |||
 | ||||||
 | ||||||
1st half 2010
(M€) |
Adjusted | Adjustments | Consolidated statement of income | |||
Sales | 78,932 | - | 78,932 | |||
Excise taxes | (9,444) | - | (9,444) | |||
Revenues from sales | 69,488 | - | 69,488 | |||
Purchases net of inventory variation | (46,330) | 700 | (45,630) | |||
Other operating expenses | (9,479) | (66) | (9,545) | |||
Exploration costs | (507) | - | (507) | |||
Depreciation, depletion and amortization of tangible assets and mineral interests | (3,448) | (8) | (3,456) | |||
Other income | 80 | 194 | 274 | |||
Other expense | (167) | (159) | (326) | |||
Financial interest on debt | (213) | - | (213) | |||
Financial income from marketable securities & cash equivalents | 48 | - | 48 | |||
Cost of net debt | (165) | - | (165) | |||
Other financial income | 213 | - | 213 | |||
Other financial expense | (190) | - | (190) | |||
Equity in income (loss) of affiliates | 1,071 | (34) | 1,037 | |||
Income taxes | (5,181) | (166) | (5,347) | |||
Consolidated net income | 5,385 | 461 | 5,846 | |||
Group share | 5,257 | 457 | 5,714 | |||
Minority interests | 128 | 4 | 132 |
TOTAL S.A.
Capital 5Â 896Â 359Â 120 euros
542 051
180 R.C.S. Nanterre
www.total.com
1 Adjusted results defined on page 2 - dollar amounts
represent euro amounts converted at the average €-$ exchange rate for
the period : 1.4391 $/€ for the 2nd quarter 2011, 1.2708 $/€
for the 2nd quarter 2010, 1.3680 $/€ for the 1st
quarter 2011, 1.4032 $/€ for the 1st half 2011 and 1.3268 $/€
for the 1st half 2010.
2 The ex-dividend date
for the interim dividend will be December 19, 2011 and the payment date
will be December 22, 2011.
3 Adjusted results (adjusted
operating income, adjusted net operating income and adjusted net income)
are defined as income using replacement cost, adjusted for special
items, excluding the impact of changes for fair value from January 1,
2011, and, through June 30, 2010, excluding Total’s equity share of
adjustments related to Sanofi. Adjusted cash flow from operations is
defined as cash flow from operations before changes in working capital
at replacement cost; adjustment items are on page 17 and the inventory
valuation effect are explained on page 14.
4 Including
acquisitions.
5 Dollar amounts represent euro amounts
converted at the average €-$ exchange rate for the period.
6
Special items affecting operating income from the business segments had
a negative impact of 63 M€ in the 2nd quarter 2011.
7
Defined as: (tax on adjusted net operating income) / (adjusted net
operating income – income from equity affiliates, dividends received
from investments and impairments of acquisition goodwill + tax on
adjusted net operating income).
8 Adjustment items
explained on page 14.
9 Detail shown on page 18.
10
Net investments = investments including acquisitions and changes in
non-current loans – asset sales.
11 Cash flow from
operations at replacement cost before changes in working capital.
12
Net cash flow = cash flow from operations - net investments.
13
Special items affecting operating income from the business segments had
a negative impact of 63 M€ in the first half 2011 and a negative impact
of 74 M€ in the first half 2010.
14 Adjustment items
explained on page 14.
15 Detail shown on page 18.
16
Cash flow from operations at replacement cost before changes in working
capital.
17 Net cash flow = cash flow from operations -
net investments.
18 Detail shown on page 19.
19
Impact of changing hydrocarbon prices on entitlement volumes.
20
Calculated based on adjusted net operating income and average capital
employed, using replacement cost, as shown on page 20.
21
Calculated based on adjusted net operating income and average capital
employed, using replacement cost, as shown on page 20.
22
Calculated based on adjusted net operating income and average capital
employed, using replacement cost, as shown on page 20.
23
Calculated based on adjusted net operating income and average capital
employed, using replacement cost, as shown on page 20.
24
Ex-dividend date will be December 19, 2011.
Total
2, place Jean Millier
La Défense 6
92 400
Courbevoie France
Tel. : 33 (1) 47 44 58 53
Fax : 33 (1) 47 44
58 24
Bertrand DE LA NOUE
Martin DEFFONTAINES
Karine
KACZKA
Laurent KETTENMEYER
Matthieu GOT
or
Robert
HAMMOND (U.S.)
Tel. : (1) 713-483-5070
Fax : (1) 713-483-5629